Conversely, Nrf2 modulators like dimethyl fumarate and sulforaphane have demonstrated endogenous activation of antioxidant enzymes (GPx, SOD, HO-1), exhibiting neuroprotective effects in AD and PD models [174]. The gene discussed is NFE2L2; the disease is Parkinson disease.